Anzeige
Mehr »
Montag, 08.12.2025 - Börsentäglich über 12.000 News
Breaking News: Das 1.000% Wachstum initiiert?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (USA)

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaArvinas Inc.: Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
SaBicara Therapeutics Inc.: Bicara Therapeutics' Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
SaBeam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
SaAptose Biosciences, Inc.: Aptose's Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
SaDisc Medicine Inc: Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
SaORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
SaWebus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
FrColabor Group Inc.: Colabor Group Announces Resignation of Director
FrClearmind Medicine Inc.: Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
FrSkyharbour Resources Ltd: Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
FrParsons Corporation: Parsons Selected As Lead Designer For $441 Million I-70 Rocheport To Columbia Design-Build Project
FrORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
FrFulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FrGlobal Mofy AI Limited Announces US$4.8 Million Private Placement Financing
FrOmega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025
FrQuanex Building Products Corporation: Quanex Building Products Declares Quarterly Dividend
FrSunrise New Energy Co., Ltd: Sunrise Signs 5,000-Ton Anode Material Supply Contract With Pylontech, Expanding Into the European Residential Energy Storage Market
FrVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FrSpyre Therapeutics, Inc.: Spyre Therapeutics Announces Grants of Inducement Awards
FrTaysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FrHingham Institution for Savings: Hingham Savings Authorizes Stock Repurchase Program
FrKymera Therapeutics, Inc.: Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025
FrNewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FrIntellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FrParsons Corporation: Parsons Selected for $1B Sound Transit MATOC to Support Regional Transit Expansion